Walleye Capital
SAGE

Walleye Capital’s Sage Therapeutics SAGE Stock Holding History

Walleye Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,800
Closed -$30.4K – 5792
2024
Q2 		$30.4K Buy
+2,800
New +$35.9K ﹤0.01% 5044
2024
Q1 		– Sell
-20,200
Closed -$438K – 5836
2023
Q4 		$438K Buy
20,200
+12,900
+177% +$256K ﹤0.01% 3052
2023
Q3 		$150K Sell
7,300
-5,100
-41% -$147K ﹤0.01% 3734
2023
Q2 		$583K Buy
+12,400
New +$617K ﹤0.01% 2314
2023
Q1 		– Sell
-3,200
Closed -$122K – 4302
2022
Q4 		$122K Sell
3,200
-2,400
-43% -$91.7K ﹤0.01% 2296
2022
Q3 		$219K Buy
+5,600
New +$216K ﹤0.01% 2048
2019
Q4 		– Sell
-20,800
Closed -$2.92M – 2205
2019
Q3 		$2.92M Buy
+20,800
New +$3.48M 0.17% 134

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return